We found that ROR1Pos CLL cells of different patients (N = 12) had significantly higher levels of MMP-9 than ROR1Neg CLL cells from each of 10 different patients (p < 0.001) (Fig. 1A, B). The gene discussed is MMP9; the disease is B-cell chronic lymphocytic leukemia.